Free subscription to the Capitol Journal keeps you current on legislative and regulatory news.
STATE NET® THOUGHT LEADERSHIP SERIES How Historic Adoption Rates Hold the Key to Forecasting Future Regulatory Action Just as state legislatures vary in their bill passage rates, some state agencies...
Judge Strikes Down Part of MD Digital Ad Tax Law A federal judge struck down a provision of Maryland’s first-in-the-nation digital advertising tax law that prohibited online companies from notifying...
NLRB Sues California to Block Labor Board Law The National Labor Relations Board has filed a lawsuit to block a new California law ( AB 288 ) empowering the state’s Public Employee Relations Board...
TX AG Sues Johnson & Johnson over Claimed Tylenol-Autism Link Texas Attorney General Ken Paxton (R) filed a lawsuit against Johnson & Johnson this week claiming the company hid the risks of Tylenol...
Over the past 47 years, seven states have enacted their own, state-level versions of the federal Community Reinvestment Act to ensure financial institutions within their jurisdictions are meeting the banking...
* The views expressed in externally authored materials linked or published on this site do not necessarily reflect the views of LexisNexis Legal & Professional.
Policymakers in California, Colorado, Maryland and other states are considering ways to backfill pandemic-era federal health insurance subsidies expiring at the end of this year. Since states don’t have the resources to replace all that federal funding, health insurance premiums are likely to soar next year. (PLURIBUS NEWS)
New Hampshire Gov. Kelly Ayotte (R) signed a bill (HB 701) allowing patients to try experimental health treatments for rare diseases. The measure expands on a law enacted by the state in 2016. (WMUR)
—Compiled by SNCJ Managing Editor KOREY CLARK
Visit our webpage to connect with a LexisNexis® State Net® representative and learn how the State Net legislative and regulatory tracking service can help you identify, track, analyze and report on relevant legislative and regulatory developments.